CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Standard BioTools Inc - LAB CFD

2.3039
1.32%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.0222
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.02629 %
Charges from full value of position ($-5.00)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.02629%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.004068 %
Charges from full value of position ($0.77)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.004068%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 2.2739
Open 2.2739
1-Year Change -3.06%
Day's Range 2.2439 - 2.3339
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jul 16, 2024 2.2739 0.1000 4.60% 2.1739 2.2839 2.1639
Jul 15, 2024 2.0939 0.0900 4.49% 2.0039 2.1039 1.9739
Jul 12, 2024 1.9639 -0.0100 -0.51% 1.9739 2.0839 1.9139
Jul 11, 2024 1.9439 0.1800 10.20% 1.7639 1.9639 1.7539
Jul 10, 2024 1.7439 -0.0600 -3.33% 1.8039 1.8139 1.7439
Jul 9, 2024 1.8339 0.0000 0.00% 1.8339 1.8739 1.8039
Jul 8, 2024 1.8439 -0.0200 -1.07% 1.8639 1.8739 1.8039
Jul 5, 2024 1.8439 0.0300 1.65% 1.8139 1.8739 1.7939
Jul 3, 2024 1.8339 0.0700 3.97% 1.7639 1.8739 1.7539
Jul 2, 2024 1.7639 0.0700 4.13% 1.6939 1.7939 1.6839
Jul 1, 2024 1.7139 -0.0300 -1.72% 1.7439 1.7739 1.6839
Jun 28, 2024 1.7539 0.0100 0.57% 1.7439 1.8139 1.7239
Jun 27, 2024 1.7539 0.0700 4.16% 1.6839 1.8239 1.6739
Jun 26, 2024 1.7139 0.0800 4.90% 1.6339 1.7639 1.5939
Jun 25, 2024 1.6439 -0.1600 -8.87% 1.8039 1.8039 1.6339
Jun 24, 2024 1.7939 -0.1200 -6.27% 1.9139 1.9539 1.7839
Jun 21, 2024 1.9139 0.0000 0.00% 1.9139 1.9339 1.8339
Jun 20, 2024 1.9139 -0.0900 -4.49% 2.0039 2.0239 1.8939
Jun 18, 2024 2.0439 -0.0400 -1.92% 2.0839 2.1039 2.0339
Jun 17, 2024 2.1039 -0.0700 -3.22% 2.1739 2.1939 2.0739

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Standard BioTools Inc Company profile

About Fluidigm Corporation

Fluidigm Corporation creates, manufactures, and markets a range of products and services, including instruments, consumables, reagents, and software that are used by researchers and clinical labs. The Company operates in development, manufacturing, and commercialization of tools for life sciences research. Its technology, mass cytometry is a multiplexed solution to analyze cell-surface and intracellular proteins simultaneously in cell suspensions including blood and disassociated tissues. Its Imaging Mass Cytometry (IMC) technology allows multiplexed imaging to understand the composition of tissue microenvironments at a subcellular 1-micron resolution. It markets technologies and life science tools, including preparatory and analytical instruments for mass cytometry, library prep, single cell genomics, and consumables, including integrated fluidic circuits (ifcs), assays, and reagents. Its analytical instruments include Biomark HD System, EP1 System, and Hyperion Tissue Imager.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Fluidigm Corporation revenues decreased 5% to $130.6M. Net loss increased 12% to $59.2M. Revenues reflect Development revenue segment decrease of 71% to $2.6M, Instruments segment decrease of 7% to $42.5M, United States segment decrease of 16% to $60.2M, Asia-Pacific segment decrease of 7% to $24M. Higher net loss reflects Research and development increase of 4% to $37.9M (expense), Selling.

Equity composition

Common Stock $0.001 Par, 2/11, 19,938,754 auth, 19,938,754 issd. Insiders own approx. 11.14%.

Industry: Advanced Medical Equipment & Technology (NEC)

2 Tower Place
Suite 2000
SOUTH SAN FRANCISCO
CALIFORNIA 94080
US

People also watch

BTC/USD

64,595.20 Price
-0.260% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

XRP/USD

0.62 Price
+5.880% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

US100

19,880.70 Price
-2.490% 1D Chg, %
Long position overnight fee -0.0263%
Short position overnight fee 0.0041%
Overnight fee time 21:00 (UTC)
Spread 1.8

Gold

2,460.29 Price
-0.360% 1D Chg, %
Long position overnight fee -0.0196%
Short position overnight fee 0.0114%
Overnight fee time 21:00 (UTC)
Spread 0.30

Still looking for a broker you can trust?

Join the 630,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading